{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:25:08Z","timestamp":1790893508903,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd002795.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000}}],"reference-count":322,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002795.pub3","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T13:10:41Z","timestamp":1646226641000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Pharmacotherapy for post traumatic stress disorder (PTSD)"],"prefix":"10.1002","volume":"2022","author":[{"given":"Taryn","family":"Williams","sequence":"additional","affiliation":[{"name":"The Department of Psychiatry and Neuroscience Institute; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole J","family":"Phillips","sequence":"additional","affiliation":[{"name":"The Department of Psychiatry and Neuroscience Institute; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan J","family":"Stein","sequence":"additional","affiliation":[{"name":"The Department of Psychiatry and Neuroscience Institute; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Ipser","sequence":"additional","affiliation":[{"name":"The Department of Psychiatry and Neuroscience Institute; University of Cape Town; Cape Town South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"235-42","DOI":"10.1159\/000362243","article-title":"Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder","volume":"69","author":"Ahmadpanah","year":"2014","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF02246271","article-title":"A double-blind randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder","volume":"122","author":"Baker","year":"1995","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0278-5846(00)00163-9","article-title":"Predictors of treatment response in patients with posttraumatic stress disorder","volume":"25","author":"Connor","year":"2001","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/JCP.0b013e318032eaed","article-title":"A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder","volume":"27","author":"Becker","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"14","key":"10.1002\/14651858.CD002795.pub3-BIB0005|cit5","first-page":"1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder","volume":"283","author":"Brady","year":"2000","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1176\/appi.ajp.158.12.1974","article-title":"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study","volume":"158","author":"Davidson","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S0033291702005469","article-title":"Characterizing the effects of sertraline in post-traumatic stress disorder","volume":"32","author":"Davidson","year":"2002","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022067512964","article-title":"Factor analysis of treatment response in posttraumatic stress disorder","volume":"16","author":"Gaffney","year":"2003","journal-title":"Journal of Traumatic Stress"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4088\/JCP.v63n0112","article-title":"Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment","volume":"63","author":"Rapaport","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002795.pub3-BIB0010|cit10","first-page":"294","article-title":"Quality of life improvement in PTSD with sertraline treatment: results of a multicenter, placebo-controlled trial","volume":"3","author":"Rapaport","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0011|cit11","first-page":"236","article-title":"Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment","volume":"51","author":"Braun","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: a pilot study","volume":"16","author":"Butterfield","year":"2001","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"386-91","DOI":"10.1002\/hup.2238","article-title":"Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study","volume":"27","author":"Carey","year":"2012","journal-title":"Human Psychopharmacology Clinical and Experimental"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"489-94","DOI":"10.1002\/hup.615","article-title":"Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial","volume":"19","author":"Chung","year":"2004","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0278-5846(01)00282-2","article-title":"Tolerability of fluoxetine in posttraumatic stress disorder","volume":"26","author":"Barnett","year":"2002","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/bjp.175.1.17","article-title":"Fluoxetine in post-traumatic stress disorder: randomized, double-blind study","volume":"175","author":"Connor","year":"1999","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1024745030140","article-title":"Quality-of-life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo- controlled trial of fluoxetine","volume":"12","author":"Malik","year":"1999","journal-title":"Journal of Traumatic Stress"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"21-5","DOI":"10.1007\/s00213-005-0265-3","article-title":"Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment","volume":"184","author":"Connor","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1990.01810150059010","article-title":"Treatment of posttraumatic stress disorder with amitriptyline and placebo","volume":"47","author":"Davidson","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.150.7.1024","article-title":"Predicting response to amitriptyline in posttraumatic stress disorder","volume":"150","author":"Davidson","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002795.pub3-BIB0021|cit21","first-page":"292","article-title":"Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder","volume":"3","author":"Davidson","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1974-81","DOI":"10.1176\/appi.ajp.158.12.1974","article-title":"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo controlled study","volume":"158","author":"Davidson","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S0033291702005469","article-title":"Characterizing the effects of sertraline in post-traumatic stress disorder","volume":"32","author":"Davidson","year":"2002","journal-title":"Psychological Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder","volume":"58","author":"Davidson","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0025|cit25","first-page":"59-65","article-title":"Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment","volume":"63","author":"Rapaport","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002795.pub3-BIB0026|cit26","first-page":"292","article-title":"Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder","volume":"3","author":"Davidson","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1176\/appi.ajp.158.12.1974","article-title":"Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study","volume":"158","author":"Davidson","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4088\/JCP.v63n0112","article-title":"Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment","volume":"63","author":"Rapaport","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-3223(02)01411-7","article-title":"Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial","volume":"53","author":"Davidson","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"166-9","DOI":"10.1097\/01.jcp.0000155817.21467.6c","article-title":"Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study","volume":"25","author":"Davidson","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial","volume":"63","author":"Davidson","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study","volume":"26","author":"Davidson","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"85-8","DOI":"10.1097\/JCP.0b013e31802e5115","article-title":"The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder","volume":"27","author":"Davidson","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0034|cit34","unstructured":"Davis LL Ambrose S English B Dafore ME Farley J A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder 20th Annual Meeting, International Society for Traumatic Stress Studies, December 6 - 9, New Orleans, LA 2001"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/01.jcp.0000125685.82219.1a","article-title":"A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study","volume":"24","author":"Davis","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"21","key":"10.1002\/14651858.CD002795.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"84-8","DOI":"10.1097\/jcp.0b013e318160f83b","article-title":"Divalproex in the treatment of posttraumatic tress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population","volume":"28","author":"Davis","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4088\/JCP.20m13267","article-title":"A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in v eterans","volume":"81","author":"Davis","year":"2020","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5498\/wjp.v10.i3.21","article-title":"Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia","volume":"10","author":"Dowd","year":"2020","journal-title":"World Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"866-74","DOI":"10.1016\/j.biopsych.2017.06.024","article-title":"Corticotropin-releasing factor receptor 1 antagonism Is ineffective for women with posttraumatic stress disorder","volume":"82","author":"Dunlop","year":"2017","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder. A randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0041|cit41","unstructured":"Unpublished data Appendix 14 of 2nd consultation draft for the NICE (2005) PTSD guidelines"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4088\/JCP.v68n0508","article-title":"Randomised, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting","volume":"68","author":"Friedman","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0043|cit43","unstructured":"A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from posttraumatic stress disorder (PTSD) https:\/\/www.gsk-studyregister.com\/en\/trial-details\/?id=29060\/648"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0044|cit44","first-page":"89","article-title":"A preliminary controlled trial of divalproex in posttraumatic stress disorder","volume":"21","author":"Hamner","year":"2008","journal-title":"Annals of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10401230009147096","article-title":"Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans","volume":"12","author":"Hertzberg","year":"2000","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"51-2","DOI":"10.1002\/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G","article-title":"Inositol treatment of posttraumatic stress disorder","volume":"2","author":"Kaplan","year":"1996","journal-title":"Anxiety"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"337-45","DOI":"10.1016\/S0278-5846(00)00163-9","article-title":"Predictors of treatment response in patients with posttraumatic stress disorder","volume":"25","author":"Connor","year":"2001","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"169-74","DOI":"10.1002\/anxi.3070010404","article-title":"Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic","volume":"1","author":"Katz","year":"1994","journal-title":"Anxiety"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"366-70","DOI":"10.1097\/00005053-199106000-00011","article-title":"Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine","volume":"179","author":"Kosten","year":"1991","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/13651501.2017.1291838","article-title":"Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study","volume":"21","author":"Li","year":"2017","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0052|cit52","unstructured":"Paxil (paroxetine) www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2001\/20-031S029.pdf"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0053|cit53","unstructured":"A 12 week, double-blind, fixed dose comparison of 20 and 40 mg daily of paroxetine and placebo in Patients suffering from Posttraumatic Stress Disorder (PTSD) GSK - clinical study register [www.gsk-clinicalstudyregister.com] Study ID: PAR 29060 651 (BRL 02960)"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Marshall R Blanco C Lewis-Fernandez R Simpson B Lin SH Garcia W Randomized controlled trial of paroxetine in adults with chronic PTSD 18th Annual Meeting, International Society for Traumatic Stress Studies, November 7 - 10, Baltimore, MD 2002","DOI":"10.1037\/e609232012-082"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0056|cit56","unstructured":"Marshall RD Lewis-Fernandez R Blanco C Simpson HB Lin S Garcia W A controlled trial of paroxetine for chronic PTSD, dissociation and interpersonal problems in mostly minority adults Draft manuscript 2004"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"77-84","DOI":"10.1002\/da","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults","volume":"24","author":"Marshall","year":"2007","journal-title":"Depression and Anxiety"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v63n0305","article-title":"Fluoxetine versus placebo in posttraumatic stress disorder","volume":"63","author":"Martenyi","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1192\/bjp.181.4.315","article-title":"Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder","volume":"181","author":"Martenyi","year":"2002","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"166-70","DOI":"10.1097\/JCP.0b013e31803308ce","article-title":"Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study","volume":"27","author":"Martenyi","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"221-9","DOI":"10.1016\/j.euroneuro.2010.11.012","article-title":"A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial","volume":"21","author":"Mathew","year":"2011","journal-title":"European Neuropsychopharmacology"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD002795.pub3-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"A351","DOI":"10.1097\/JCP.0000000000000968","article-title":"A randomized controlled trial (RCT) of prazosin versus placebo for suicidal posttraumatic stress disorder (PTSD) patients with nightmares-a pilot study","volume":"41","author":"McCall","year":"2018","journal-title":"Sleep"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"190-6","DOI":"10.1002\/da.20008","article-title":"Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder","volume":"19","author":"McRae","year":"2004","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0064|cit64","unstructured":"Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF\/OEF Veterans (Nepicastat) clinicaltrials.gov\/ct2\/show\/NCT00659230"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0065|cit65","unstructured":"Orvepitant (GW823296) in adult Post Traumatic Stress Disorder clinicaltrials.gov\/ct2\/show\/NCT01000493"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0066|cit66","unstructured":"Neural circuits in women with abuse and Posttraumatic Stress Disorder clinicaltrials.gov\/ct2\/show\/NCT01681849"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"275-80","DOI":"10.1097\/00004850-200609000-00005","article-title":"Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women","volume":"21","author":"Padala","year":"2006","journal-title":"International Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"2159-66","DOI":"10.1017\/S0033291711000201","article-title":"A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder","volume":"41","author":"Panahi","year":"2011","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0069|cit69","unstructured":"Review and evaluation of clinical data [Pfizer NDA application: Sertraline (Zoloft) for PTSD] www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/19-839S026_Zoloft_Clinr_P1.pdf 1999 (accessed 28 November 2021)"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0070|cit70","unstructured":"Unpublished data Appendix 14 of 2nd consultation draft for the NICE (2005) PTSD guidelines"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0071|cit71","unstructured":"Review and evaluation of clinical data [Pfizer NDA application: Sertraline (Zoloft) for PTSD] www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/19-839S026_Zoloft_Clinr_P1.pdf 1999 (accessed 28 November 2021)"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4088\/JCP.v68n0508","article-title":"Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting","volume":"68","author":"Friedman","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0073|cit73","unstructured":"Unpublished data Appendix 14 of 2nd consultation draft for the NICE (2005) PTSD guidelines"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1507598","article-title":"Trial of prazosin for post-traumatic stress disorder in military veterans","volume":"378","author":"Raskind","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD002795.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"2245-57","DOI":"10.1007\/s00213-017-4649-y","article-title":"A randomized controlled trial of ganaxolone in posttraumatic stress disorder","volume":"234","author":"Rasmusson","year":"2017","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4088\/JCP.v65n1204","article-title":"A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women","volume":"65","author":"Reich","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0278-5846(95)00024-P","article-title":"REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder","volume":"19","author":"Reist","year":"1995","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1176\/ajp.146.4.513","article-title":"A controlled trial of desipramine in 18 men with posttraumatic stress disorder","volume":"146","author":"Reist","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0079|cit79","first-page":"1","article-title":"Nefazodone versus sertraline in treatment of posttraumatic stress disorder","volume":"12","author":"Saygin","year":"2002","journal-title":"Bulletin of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-1781(88)90057-1","article-title":"A controlled trial of phenelzine in posttraumatic stress disorder","volume":"24","author":"Shestatzky","year":"1988","journal-title":"Psychiatric Research"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0081|cit81","unstructured":"NDA 20-031\/S-029 Paxil (paroxetine hydrochloride) tablets; GlaxoSmithKline; Post-traumatic Stress Disorder www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2001\/20-031S029.pdf (accessed 28 November 2021)"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0082|cit82","unstructured":"A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from posttraumatic stress disorder (PTSD) GSK - clinical study register [www.gsk-clinicalstudyregister.com] Study ID: 29060\/627"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0083|cit83","unstructured":"Unpublished data Appendix 14 of 2nd consultation draft for the NICE (2005) PTSD guidelines"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1517\/14656566.4.10.1829","article-title":"Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies","volume":"4","author":"Stein","year":"2003","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0085|cit85","unstructured":"Unpublished data Appendix 14 of 2nd consultation draft for the NICE (2005) PTSD guidelines"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1011177420069","article-title":"Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms","volume":"14","author":"Smajkic","year":"2001","journal-title":"Journal of Traumatic Stress"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"152-6","DOI":"10.1097\/01.jcp.0000203195.65710.f0","article-title":"Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial","volume":"26","author":"Spivak","year":"2006","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0088|cit88","unstructured":"A 12-week, double-blind, placebo-controlled, parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from posttraumatic stress disorder (PTSD) GSK - Clinical Study Register [www.gsk-clinicalstudyregister.com] 2000 Study ID:GSK 29060\/648"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Tucker","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0090|cit90","first-page":"135","article-title":"Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo","volume":"37","author":"Tucker","year":"2003","journal-title":"General Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Tucker","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0092|cit92","first-page":"517","article-title":"Fluoxetine treatment in posttraumatic stress disorder","volume":"55","author":"Van der Kolk","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0093|cit93","unstructured":"Spinazzola J Blaustein M Hopper J Hopper E Korn D A randomized clinical trial of EMDR, fluoxetine and pill placebo in the treatment of PTSD: treatment effects and long-term maintenance Draft manuscript 2004"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.v68n0105","article-title":"A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance","volume":"68","author":"Van der Kolk","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1176\/appi.ajp.2016.15070967","article-title":"Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial","volume":"173","author":"Villarreal","year":"2016","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"305-10","DOI":"10.1111\/j.1755-5949.2010.00188.x","article-title":"A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD","volume":"17","author":"Yeh","year":"2011","journal-title":"CNS Neuroscience and Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002795.pub3-BIB0097|cit97","first-page":"269","article-title":"A placebo-controlled study of sertraline in posttraumatic stress disorder","volume":"3","author":"Amital","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0098|cit98","unstructured":"Amital D Zohar J Kotler M Bleich A Miodovnik H Nevo A A placebo-controlled trial pilot study of sertraline in PTSD Annual Meeting of the American Psychiatric Association American Psychiatric Association 1999 157"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004714-200204000-00013","article-title":"Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder","volume":"22","author":"Zohar","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1176\/appi.ajp.161.8.1488","article-title":"Low-dose cortisol for symptoms of posttraumatic stress disorder","volume":"161","author":"Aerni","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"Supplement 2","key":"10.1002\/14651858.CD002795.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S698","DOI":"10.1016\/j.euroneuro.2019.01.088","article-title":"P.3.26 Effects of hydrocortisone on cognitive performance and threat-interference under acute stress in highly anxious females","volume":"29","author":"Angelidis","year":"2019","journal-title":"European Neuropsychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"e1439","DOI":"10.4088\/JCP.15m10239","article-title":"A double-blind, randomized, controlled pilot trial of N-Acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders","volume":"77","author":"Back","year":"2016","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cct.2018.08.009","article-title":"Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: design and methodology of a randomized controlled trial in military veterans","volume":"73","author":"Back","year":"2018","journal-title":"Contemporary Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopsych.2004.11.039","article-title":"Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder","volume":"57","author":"Bartzokis","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"2169-77","DOI":"10.1111\/acer.12496","article-title":"Topiramate treatment of alcohol use disorder in veterans with PTSD: a randomized controlled pilot trial","volume":"38","author":"Batki","year":"2014","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jts.22335","article-title":"Posttraumatic stress symptoms and emerging adult sexual minority men: implications for assessment and treatment of childhood sexual abuse","volume":"31","author":"Boroughs","year":"2018","journal-title":"Journal of Traumatic Stress"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/BOT.0000000000001342","article-title":"Prospective study of the effectiveness of paroxetine on the onset of posttraumatic stress disorder, depression, and health and functional outcomes after trauma","volume":"33","author":"Starr","year":"2019","journal-title":"Journal of Orthopaedic Trauma"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1037\/tra0000309","article-title":"Treatment of co-occurring posttraumatic stress disorder and substance use: does order of onset influence outcomes?","volume":"10","author":"Bountress","year":"2018","journal-title":"Psychological Trauma: Theory, Research, Practice and Policy"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"395-401","DOI":"10.1097\/01.ALC.0000156129.98265.57","article-title":"Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder","volume":"29","author":"Brady","year":"2005","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1997.01830150070011","article-title":"Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder","volume":"54","author":"Bremner","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1176\/appi.ajp.2017.17050481","article-title":"Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial","volume":"175","author":"Brunet","year":"2018","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.psychres.2018.03.069","article-title":"Long-term treatment effect of trauma-affected refugees with flexible cognitive behavioural therapy and antidepressants","volume":"264","author":"Buhmann","year":"2018","journal-title":"Psychiatry Research"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0006-3223(97)00043-7","article-title":"A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder","volume":"41","author":"Coupland","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0114|cit114","unstructured":"Eftekhari A Miller H Zoellner L Feeny N Prolonged exposure vs. sertraline: Secondary outcomes in PTSD treatment 20th Annual Meeting, International Society for Traumatic Stress Studies, November 14 - November 18, New Orleans, LA 2004"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"193-202","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1037\/pha0000197","article-title":"Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder","volume":"26","author":"Flanagan","year":"2018","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1037\/pha0000232","article-title":"Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder","volume":"27","author":"Flanagan","year":"2019","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1176\/ajp.145.10.1289","article-title":"A randomized clinical trial of phenelzine and imipramine for post-traumatic stress disorder","volume":"145","author":"Frank","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1302652","DOI":"10.1080\/20008198.2017.1302652","article-title":"Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals","volume":"8","author":"Frijling","year":"2017","journal-title":"European Journal of Psychotraumatology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0120|cit120","unstructured":"Frommberger U Nyberg E Richter H Stieglitz RD Berger M Paroxetine vs. cognitive-behavioral therapy in the treatment of depression in PTSD patients XXIst Collegium Internationale Neuro psychopharmacologicum, Glasgow, Scotland. 12th 16th July 1998"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0121|cit121","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: a prospective study","volume":"57","author":"Gelpin","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1192\/bjp.2018.211","article-title":"High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder","volume":"213","author":"Graham","year":"2018","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1520-6394(1997)5:3<137::AID-DA6>3.0.CO;2-B","article-title":"Buspirone potentiation of antidepressants in the treatment of PTSD","volume":"5","author":"Hamner","year":"1997","journal-title":"Depression and Anxiety"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1099-1077(199903)14:2<105::AID-HUP75>3.0.CO;2-E","article-title":"Procaine administration and behavioral responsivity in post-traumatic stress disorder: a pilot study of tolerability","volume":"14","author":"Hamner","year":"1999","journal-title":"Human Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0125|cit125","first-page":"1","article-title":"Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms","volume":"18","author":"Hamner","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145702003061","article-title":"Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder","volume":"5","author":"Heresco-Levy","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"9 Supplement 1","key":"10.1002\/14651858.CD002795.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"S352","DOI":"10.1016\/j.biopsych.2018.02.905","article-title":"Randomized controlled trial of hydrocortisone and D-cycloserine on fear extinction in PTSD","volume":"83","author":"Inslicht","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1176\/appi.ajp.157.9.1525","article-title":"Posttraumatic stress disorder and sleep difficulty","volume":"157","author":"Jacobs-Rebhun","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-3223(01)01158-1","article-title":"Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder","volume":"50","author":"Kanter","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-3223(99)00118-3","article-title":"Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder","volume":"47","author":"Kellner","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s11136-018-1833-4","article-title":"Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD)","volume":"27","author":"Le","year":"2018","journal-title":"Quality of Life Research"},{"issue":"28","key":"10.1002\/14651858.CD002795.pub3-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-9-28","article-title":"A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder","volume":"9","author":"Mello","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF02246220","article-title":"Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder","volume":"117","author":"Grillon","year":"1995","journal-title":"Psychopharmacology"},{"issue":"0","key":"10.1002\/14651858.CD002795.pub3-BIB0135|cit135","doi-asserted-by":"publisher","first-page":"318-20","DOI":"10.1016\/j.psychres.2012.11.008","article-title":"A pilot randomized controlled trial with paroxetine for subthreshold PTSD in operation enduring freedom\/operation Iraqi freedom era veterans","volume":"206","author":"Naylor","year":"2013","journal-title":"Psychiatry Research Journal"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0136|cit136","unstructured":"Clinical evaluation of BRL29060A (paroxetine hydrochloride hydrate) in posttraumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/ NCT00557622"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0137|cit137","unstructured":"Effectiveness of propranolol for treating people with post-traumatic stress disorder clinicaltrials.gov\/ct2\/show\/record\/NCT00648375"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0138|cit138","unstructured":"Trial of hydrocortisone for post-traumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT00706173"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0139|cit139","unstructured":"The effect of intranasal oxytocin on emphatic abilities in patients with post traumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT01325168"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0140|cit140","unstructured":"Rapamycin as a means of interference with reconsolidation of posttraumatic stress disorder-related traumatic memory clinicaltrials.gov\/ct2\/show\/record\/NCT01449955"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0141|cit141","unstructured":"Cortisol suppression and startle responses in posttraumatic stress disorder (PTSD) (CSS) clinicaltrials.gov\/ct2\/show\/record\/NCT01477762"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0142|cit142","unstructured":"Efficacy mechanism of N-acetylcysteine in patients with posttraumatic stress disorder clinicaltrials.gov\/ct2\/show\/record\/NCT01664260"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2186-8","DOI":"10.1176\/ajp.2006.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment","volume":"163","author":"Neylan","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0005-7967(03)00032-9","article-title":"Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone","volume":"41","author":"Otto","year":"2003","journal-title":"Behaviour Research and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13148-018-0569-x","article-title":"DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder","volume":"10","author":"Pape","year":"2018","journal-title":"Clinical Epigenetics"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.biopsych.2006.03.074","article-title":"Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder","volume":"60","author":"Petrakis","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archpsyc.1990.01810180041007","article-title":"Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder","volume":"47","author":"Pitman","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-3223(01)01279-3","article-title":"Pilot study of secondary prevention of posttraumatic stress disorder with propranolol","volume":"51","author":"Pitman","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4088\/JCP.09m05607gry","article-title":"Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Pollack","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conctc.2015.12.003","article-title":"Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder","volume":"2","author":"Ramaswamy","year":"2016","journal-title":"Contemporary Clinical Trials Communications"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"17m02138","DOI":"10.4088\/PCC.17m02138","article-title":"A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression","volume":"19","author":"Ramaswamy","year":"2017","journal-title":"Primary Care Companion for CNS Disorders"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-3223(94)00306-N","article-title":"Effects of the benzodiazepine antagonist flumazenil in PTSD","volume":"38","author":"Randall","year":"1995","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study","volume":"160","author":"Raskind","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"928-34","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder","volume":"61","author":"Raskind","year":"2007","journal-title":"Society of Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0278-5846(95)00024-P","article-title":"REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder","volume":"19","author":"Reist","year":"1995","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1461145701002607","article-title":"Beta-adrenergic blockade and emotional memory in PTSD","volume":"4","author":"Reist","year":"2001","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0158|cit158","unstructured":"Roache JD Raj JJ Blount T Hale W Murff WR SSRI treatment of dual diagnosis PTSD and alcohol dependence In veterans: opposite effects of sertraline In EOA and LOA subtypes UT Health Science Center at San Antonio and South Texas Veterans Health Care System, San Antonio, TX, USA 2017"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2003.09.014","article-title":"Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study","volume":"55","author":"Schelling","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpsyc.1997.01830200083012","article-title":"Noradrenergic and serotonergic function in posttraumatic stress disorder","volume":"54","author":"Southwick","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study","volume":"159","author":"Stein","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0162|cit162","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00332747.2017.1286892","article-title":"Facilitating fear-based memory extinction with dexamethasone: a randomized controlled trial in male veterans with combat-related PTSD","volume":"80","author":"Suris","year":"2017","journal-title":"Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-3223(03)00412-8","article-title":"Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma","volume":"54","author":"Vaiva","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0164|cit164","first-page":"417","article-title":"Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder","volume":"25","author":"Van der Kolk","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/acer.13969","article-title":"Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder","volume":"43","author":"Verplaetse","year":"2019","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0166|cit166","unstructured":"Davis L Petty F GABAergic modulation in PTSD and treatment with anticonvulsants In: 19th Annual Meeting, International Society for Traumatic Stress Studies, October 29 - November 1, Chicago, IL 2003"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0167|cit167","unstructured":"Nagy LM Southwick SM Charney DS Placebo-controlled trial of fluoxetine in PTSD International Society for Traumatic Stress Studies 12th Annual Meeting, San Francisco, CA, November 11 1996"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0168|cit168","unstructured":"Levetiracetam in post-traumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT00413296"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0169|cit169","unstructured":"Effects of Paxil CR on neural circuits in posttraumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT00672776"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0170|cit170","unstructured":"Tramadol Extended-Release (ER) for posttraumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT01517711"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0171|cit171","unstructured":"Vortioxetine for posttraumatic stress disorder clinicaltrials.gov\/ct2\/show\/record\/NCT02637895"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0172|cit172","unstructured":"A controlled trial of losartan in posttraumatic stress disorder (LOSe-PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT02709018"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0173|cit173","unstructured":"Phase II study of BNC210 in PTSD (RESTORE) clinicaltrials.gov\/ct2\/show\/record\/NCT02933606"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0174|cit174","unstructured":"Carvedilol versus placebo for treatment in post traumatic stress disorder (PTSD) clinicaltrials.gov\/ct2\/show\/record\/NCT01221792"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3956(02)00058-4","article-title":"Psychopharmacological treatment in PTSD: a critical review","volume":"36","author":"Albucher","year":"2002","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"JAMA"},{"issue":"Issue 7. Art. N","key":"10.1002\/14651858.CD002795.pub3-BIB0177|cit177","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006239.pub2","article-title":"Pharmacological interventions for preventing post-traumatic stress disorder (PTSD)","author":"Amos","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0178|cit178","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0179|cit179","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0180|cit180","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental Disorders, fifth edition","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00003495-200464040-00004","article-title":"SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations","volume":"64","author":"Asnis","year":"2004","journal-title":"Drugs"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0182|cit182","first-page":"559","article-title":"The promise and problems of meta-analysis","volume":"337","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1192\/03-2","article-title":"Quantitative analysis of sponsorship bias in economic studies of antidepressants","volume":"183","author":"Baker","year":"2003","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"Journal of Psychopharmacology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD002795.pub3-BIB0185|cit185","first-page":"60","article-title":"Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety","volume":"61","author":"Ballenger","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002795.pub3-BIB0186|cit186","first-page":"55","article-title":"Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety","volume":"65","author":"Ballenger","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-raumatic tress disorders -first revision","volume":"9","author":"Bandelow","year":"2008","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00976812","article-title":"Amitriptyline for PTSD in a torture survivor: a case study","volume":"5","author":"Basoglu","year":"1992","journal-title":"Journal of Traumatic Stress"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.copsyc.2017.01.003","article-title":"Pharmacological management of posttraumatic stress disorder","volume":"14","author":"Bernardy","year":"2017","journal-title":"Current Opinion in Psychology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0191|cit191","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003388.pub3","article-title":"Psychological treatment of post-traumatic stress disorder (PTSD)","author":"Bisson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0192|cit192","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003388.pub4","article-title":"Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults","author":"Bisson","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0193|cit193","first-page":"187","article-title":"A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1","volume":"21","author":"Blake","year":"1990","journal-title":"Behavior Therapy"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1192\/bjp.149.3.365","article-title":"Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment","volume":"149","author":"Bleich","year":"1986","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","article-title":"A multidimensional meta-analysis of psychotherapy for PTSD","volume":"162","author":"Bradley","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1196\/annals.1314.012","article-title":"Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder","volume":"1032","author":"Bremner","year":"2004","journal-title":"Annals of the New York Academy of Science"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archpsyc.1991.01810270028003","article-title":"Traumatic events and post traumatic stress disorder in an urban population of young adults","volume":"48","author":"Breslau","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1037\/0022-006X.57.5.607","article-title":"Brief psychotherapy for posttraumatic stress disorders","volume":"57","author":"Brom","year":"1989","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/milmed\/156.2.100","article-title":"Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder","volume":"156","author":"Brophy","year":"1991","journal-title":"Military Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000054884","article-title":"Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment","volume":"43","author":"Brunello","year":"2001","journal-title":"Neuropsychobiology"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0033-3182(84)72977-X","article-title":"Treatment of posttraumatic stress disorder with imipramine","volume":"25","author":"Burstein","year":"1984","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.156.5.761","article-title":"Categorizing fear: the role of trauma in a clinical formulation","volume":"156","author":"Burton","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"6499","key":"10.1002\/14651858.CD002795.pub3-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"702-4","DOI":"10.1038\/371702a0","article-title":"\u03b2-adrenergic activation and memory for emotional events","volume":"371","author":"Cahill","year":"1994","journal-title":"Nature"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1749-6632.1997.tb48318.x","article-title":"MRI reveals gross structural abnormalities in PTSD","volume":"821","author":"Canive","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-199810000-00005","article-title":"Bupropion treatment in veterans with posttraumatic stress disorder: an open study","volume":"18","author":"Canive","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archpsyc.1993.01820160064008","article-title":"Psychobiologic mechanisms of posttraumatic stress disorder","volume":"50","author":"Charney","year":"1993","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1176\/appi.ajp.161.2.195","article-title":"Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress","volume":"161","author":"Charney","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1176\/ajp.148.8.1087","article-title":"The obsessive quality and clomipramine treatment of PTSD","volume":"148","author":"Chen","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"7S2","key":"10.1002\/14651858.CD002795.pub3-BIB0209|cit209","first-page":"43","article-title":"The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy","volume":"3","author":"Connor","year":"1998","journal-title":"CNS Spectrums"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004850-199901000-00003","article-title":"A pilot study of mirtazapine in post-traumatic stress disorder","volume":"14","author":"Connor","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1097\/00002826-198406001-00458","article-title":"Primary depression or primary anxiety: a possible psychometric approach to a diagnostic dilemma","volume":"7","author":"Covi","year":"1984","journal-title":"Clinical Neuropharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1489-96","DOI":"10.1016\/j.brat.2003.07.010","article-title":"Psychometric properties of the Impact of Event Scale-Revised","volume":"41","author":"Creamer","year":"2003","journal-title":"Behaviour Research and Therapy"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0213|cit213","unstructured":"Committee on Safety of Medicines Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants https:\/\/www.neuroscience.ox.ac.uk\/publications\/474047 2005"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1345\/aph.19120","article-title":"Treatment for posttraumatic stress disorder","volume":"34","author":"Cyr","year":"2000","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1192\/bjp.150.2.252","article-title":"A pilot study of phenelzine in the treatment of post-traumatic stress disorder","volume":"150","author":"Davidson","year":"1987","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0216|cit216","first-page":"422","article-title":"Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions","volume":"25","author":"Davidson","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD002795.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.150.7.1024","article-title":"Predicting response to amitriptyline in posttraumatic stress disorder","volume":"150","author":"Davidson","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00004850-199711000-00001","article-title":"Response characteristics to antidepressants and placebo in post-traumatic stress disorder","volume":"12","author":"Davidson","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"issue":"Suppl 9","key":"10.1002\/14651858.CD002795.pub3-BIB0219|cit219","first-page":"33","article-title":"Biological therapies for posttraumatic stress disorder: an overview","volume":"58","author":"Davidson","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0033291796004229","article-title":"Assessment of a new self-rating scale for posttraumatic stress disorder","volume":"27","author":"Davidson","year":"1997","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004714-199802000-00020","article-title":"Fluvoxamine in civilians with posttraumatic stress disorder","volume":"18","author":"Davidson","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD002795.pub3-BIB0222|cit222","first-page":"52","article-title":"Pharmacotherapy of posttraumatic stress disorder: treatment options, long term follow-up, and predictors of outcome","volume":"61","author":"Davidson","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0223|cit223","unstructured":"Davies SJ Champion C Dawson S Sharp J Churchill R The Subway Map - a new way to visualize antidepressant classification (a Cochrane CCDAN initiative) 14th ICGP and 19th JSNP Joint Congress; 3 October. Tsukuba, Japan, 2014: 78. [Abstract P14] 2015"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004714-200004000-00007","article-title":"Nefazodone treatment for chronic posttraumatic stress disorder: an open trial","volume":"20","author":"Davis","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0225|cit225","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0227|cit227","volume-title":"The Cochrane Library","author":"Deeks","year":"2003"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0228|cit228","first-page":"285-12","volume-title":"Egger M, Davey SG, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition","author":"Deeks","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0229|cit229","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jama.286.5.555","article-title":"Lifetime events and posttraumatic stress disorder in 4 postconflict settings","volume":"286","author":"De Jong","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00007611-199311000-00022","article-title":"Use of thioridazine in post-traumatic stress disorder","volume":"86","author":"Dillard","year":"1993","journal-title":"Southern Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10401239709147767","article-title":"Antidepressant treatment of posttraumatic stress disorder and major depression in veterans","volume":"9","author":"Dow","year":"1997","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0232|cit232","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/10401239209149571","article-title":"Rapid response to buspirone in a case of post-traumatic stress disorder","volume":"4","author":"Duffy","year":"1992","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401239409148837","article-title":"Efficacy of buspirone in the treatment of posttraumatic stress disorder: An open trial","volume":"6","author":"Duffy","year":"1994","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0234|cit234","unstructured":"Dunner FJ Edwards WP Copeland PC Clinical efficacy of alprazolam in PTSD patients 138th Annual Meeting of the American Psychiatric Association, Los Angeles, CA 1985"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: Methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0236|cit236","first-page":"385","article-title":"Tricyclics: possible treatment for post-traumatic stress disorder","volume":"46","author":"Falcon","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archpedi.1988.02150110122036","article-title":"Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study","volume":"142","author":"Famularo","year":"1988","journal-title":"American Journal of Diseases of Children"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0238|cit238","first-page":"361","article-title":"Valproate in combat-related posttraumatic stress disorder","volume":"52","author":"Fesler","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0006-3223(90)90040-9","article-title":"Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality","volume":"27","author":"Fichtner","year":"1990","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0024-3205(94)00592-3","article-title":"Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response","volume":"54","author":"Fichtner","year":"1994","journal-title":"Life Sciences"},{"issue":"Suppl. 16","key":"10.1002\/14651858.CD002795.pub3-BIB0241|cit241","first-page":"1","article-title":"The expert consensus guideline series: treatment of posttraumatic stress disorder: the expert consensus panel for PTSD","volume":"60","author":"Foa","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/jts.2490090413","article-title":"The use of anticonvulsants in posttraumatic stress disorder: case study and overview","volume":"9","author":"Ford","year":"1996","journal-title":"Journal of Traumatic Stress"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jts.2490080110","article-title":"Lithium for irritability in post-traumatic stress disorder","volume":"8","author":"Forster","year":"1994","journal-title":"Journal of Traumatic Stress"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4088\/JCP.15m10060","article-title":"Generalizability of pharmacologic and psychotherapy clinical trial results for posttraumatic stress disorder to community samples","volume":"77","author":"Franco","year":"2016","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0245|cit245","unstructured":"Friedman MJ PTSD: National Center for PTSD U.S Department of Veterans Affairs 2016"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1007793803627","article-title":"Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder","volume":"13","author":"Gersons","year":"2000","journal-title":"Journal of Trauma Stress"},{"issue":"10","key":"10.1002\/14651858.CD002795.pub3-BIB0247|cit247","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jaac.2010.07.014","article-title":"Prolonged exposure versus dynamic therapy for adolescent PTSD: a pilot randomized controlled trial","volume":"49","author":"Gilboa-Schechtman","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0248|cit248","volume-title":"Encyclopaedia of Clinical Psychology","author":"Gist","year":"2015"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0249|cit249","first-page":"255","article-title":"A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder","volume":"30","author":"Glover","year":"1993","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0010-440X(98)90076-1","article-title":"Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder","volume":"39","author":"Gupta","year":"1998","journal-title":"Comprehensive Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0251|cit251","first-page":"470","article-title":"Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability","volume":"25","author":"Gury","year":"1999","journal-title":"Encephale"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0252|cit252","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1176\/ajp.153.6.841","article-title":"Clozapine treatment for a veteran with comorbid psychosis and PTSD (letter)","volume":"153","author":"Hamner","year":"1996","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004850-199809000-00008","article-title":"Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder","volume":"13","author":"Hamner","year":"1998","journal-title":"International Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00004583-199609000-00022","article-title":"Clonidine for posttraumatic stress disorder in preschool children","volume":"35","author":"Harmon","year":"1996","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0272-7358(03)00035-7","article-title":"Cognitive behaviour therapy for posttraumatic stress disorder","volume":"23","author":"Harvey","year":"2003","journal-title":"Clinical Psychology Review"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004714-199608000-00004","article-title":"Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design","volume":"16","author":"Hertzberg","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4088\/JCP.v59n0904","article-title":"Open trial of nefazodone for combat-related posttraumatic stress disorder","volume":"59","author":"Hertzberg","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199903000-00001","article-title":"Nefazodone in posttraumatic stress: results from six open-label trials","volume":"14","author":"Hidalgo","year":"1999","journal-title":"International Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0263|cit263","unstructured":"Higgins JP Greens S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archpsyc.1981.01780290074008","article-title":"Treatment of traumatic war neurosis with phenelzine","volume":"38","author":"Hogben","year":"1981","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/sim.1191","article-title":"A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials","volume":"21","author":"Hopewell","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","article-title":"Impact of Event Scale: a measure of subjective stress","volume":"41","author":"Horowitz","year":"1979","journal-title":"Psychosomatic Medicine"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00004583-199608000-00006","article-title":"Guanfacine for PTSD nightmares","volume":"35","author":"Horrigan","year":"1996","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0268|cit268","doi-asserted-by":"publisher","first-page":"93-100","DOI":"10.1192\/bjp.bp.114.148551","article-title":"Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis","volume":"206","author":"Hoskins","year":"2015","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"825-40","DOI":"10.1017\/S1461145711001209","article-title":"Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)","volume":"15","author":"Ipser","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10401238909149968","article-title":"Pharmacologic treatment of veterans with posttraumatic stress disorder and concomitant affective disorder","volume":"1","author":"Irwin","year":"1989","journal-title":"Annals of Clinical Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3928\/0048-5713-19980801-04","article-title":"Schizoaffective disorder and PTSD successfully treated with olanzapine and supportive psychotherapy","volume":"28","author":"Izrayelit","year":"1998","journal-title":"Psychiatric Annals"},{"issue":"1S","key":"10.1002\/14651858.CD002795.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004714-199202001-00006","article-title":"Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders","volume":"12","author":"Keck","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0274|cit274","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002795.pub3-BIB0275|cit275","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005053-198909000-00005","article-title":"Clonidine in Cambodian patients with post traumatic stress disorder","volume":"177","author":"Kinzie","year":"1989","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"13","key":"10.1002\/14651858.CD002795.pub3-BIB0276|cit276","doi-asserted-by":"publisher","first-page":"2260-74","DOI":"10.1017\/S0033291717000708","article-title":"Posttraumatic stress disorder in the World Mental Health Surveys","volume":"47","author":"Koenen","year":"2017","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0277|cit277","first-page":"98","volume-title":"Post-traumatic Stress Disorder: Psychological and Biological Sequelae","author":"Kolb","year":"1984"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004714-199204000-00010","article-title":"Buspirone in the treatment of posttraumatic stress disorder","volume":"12","author":"LaPorta","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archpsyc.1987.01800230056010","article-title":"Posttraumatic stress disorder in Israeli combat veterans: effect of phenelzine treatment","volume":"44","author":"Lerer","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/ps.49.2.245","article-title":"Risperidone in PTSD","volume":"49","author":"Leyba","year":"1998","journal-title":"Psychiatric Services"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0281|cit281","first-page":"449","article-title":"Trazodone for the treatment of anxiety symptoms in substance abusers","volume":"9","author":"Liebowitz","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0033-3182(86)72590-5","article-title":"Preliminary study of carbamazepine in post traumatic stress disorder","volume":"27","author":"Lipper","year":"1986","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1002\/14651858.CD002795.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004583-199506000-00008","article-title":"Carbamazepine for PTSD","volume":"34","author":"Looff","year":"1995","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0284|cit284","first-page":"3","article-title":"Open trial of clonazepam in the treatment of post traumatic stress symptoms in multiple personality disorder","volume":"1","author":"Lowenstein","year":"1988","journal-title":"Dissociation"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3928\/0048-5713-19960401-12","article-title":"Psychopharmacology of posttraumatic stress disorder","volume":"26","author":"Marshall","year":"1996","journal-title":"Psychiatric Annals"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0286|cit286","first-page":"133","volume-title":"Psychological Trauma","author":"Marshall","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00004714-199802000-00003","article-title":"An open trial of paroxetine in patients with noncombat-related posttraumatic stress disorder","volume":"18","author":"Marshall","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0288|cit288","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/hrp.7.5.247","article-title":"Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy","volume":"7","author":"Marshall","year":"2000","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0289|cit289","first-page":"40","article-title":"Phenelzine treatment of post-vietnam stress syndrome","volume":"1","author":"Milanes","year":"1984","journal-title":"VA Practitioner"},{"issue":"9193","key":"10.1002\/14651858.CD002795.pub3-BIB0290|cit290","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0292|cit292","volume-title":"Cochrane Collaboration Handbook","author":"Mulrow","year":"1997"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004850-199707000-00008","article-title":"An open trial of moclobemide in the treatment of post-traumatic stress disorder","volume":"12","author":"Neal","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0294|cit294","unstructured":"Post-traumatic stress disorder: management (NG116). Clinical guideline Published: December 2018 National Institute for Health and Care Excellence 2018"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jts.2490030309","article-title":"Affective disorders, DST, and treatment in PTSD patients: clinical observations","volume":"3","author":"Olivera","year":"1990","journal-title":"Journal of Traumatic Stress"},{"issue":"5","key":"10.1002\/14651858.CD002795.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1520-6394(1996)4:5<240::AID-DA6>3.0.CO;2-H","article-title":"Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies","volume":"4","author":"Penava","year":"1996","journal-title":"Depression and Anxiety"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0297|cit297","doi-asserted-by":"publisher","first-page":"24-39","DOI":"10.1016\/j.brainres.2009.03.037","article-title":"Pharmacotherapy of PTSD: premises, principles, and priorities","volume":"1293","author":"Ravindran","year":"2009","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0298|cit298","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMe1716724","article-title":"Alpha-adrenergic receptors in PTSD -failure or time for precision medicine?","volume":"378","author":"Ressler","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0299|cit299","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/A:1024441315913","article-title":"Brief early psychological interventions following trauma: a systematic review of the literature","volume":"11","author":"Rose","year":"1998","journal-title":"Journal of Traumatic Stress"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0301|cit301","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000560","article-title":"Psychological debriefing for preventing post traumatic stress disorder (PTSD)","author":"Rose","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0302|cit302","unstructured":"Rubin MR Solt V Anafranil's effect on the obsessions and sleep in PTSD Proceedings and Abstracts of the 146th Annual Meeting of the American Psychiatric Association, San Francisco, CA 1993 102"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0303|cit303","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(01)02672-1","article-title":"Acute war neuroses","volume":"140","author":"Sargent","year":"1940","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD002795.pub3-BIB0304|cit304","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00006842-199603000-00012","article-title":"Treatment of posttraumatic stress disorder: a review","volume":"58","author":"Shalev","year":"1996","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11 Suppl 3","author":"Sheehan","year":"1996","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD002795.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"263","DOI":"10.31887\/DCNS.2011.13.2\/jsherin","article-title":"Post-traumatic stress disorder: the neurobiological impact of psychological trauma","volume":"13","author":"Sherin","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jts.2490040213","article-title":"Buspirone, benzodiazepines, and post-traumatic stress disorder","volume":"4","author":"Simpson","year":"1991","journal-title":"Journal of Traumatic Stress"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD002795.pub3-BIB0308|cit308","first-page":"1","article-title":"Trauma: prevalence, impairment, service use, and cost","volume":"58","author":"Solomon","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0309|cit309","volume-title":"Instructional manual for the structured clinical interview for DSM-IV","author":"Spitzer","year":"1996"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0310|cit310","volume-title":"Stahl\u2019s essential psychopharmacology. Neuroscientific Basis and Practical Application. Fourth Edition","author":"Stahl","year":"2013"},{"issue":"8","key":"10.1002\/14651858.CD002795.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1176\/ajp.148.8.1086b","article-title":"Divalproex in posttraumatic stress disorder","volume":"148","author":"Szymanski","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"6965","key":"10.1002\/14651858.CD002795.pub3-BIB0312|cit312","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thomson","year":"1994","journal-title":"BMJ"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD002795.pub3-BIB0313|cit313","first-page":"3","article-title":"Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder","volume":"161","author":"Ursano","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0314|cit314","doi-asserted-by":"crossref","unstructured":"Verbeke M Molenberghs G Linear mixed models for longitudinal data New York: Springer 2000","DOI":"10.1007\/978-1-4419-0300-6"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnbeh.2018.00258","article-title":"Treating PTSD: a review of evidence-based psychotherapy interventions","volume":"12","author":"Watkins","year":"2018","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1037\/1040-3590.11.2.124","article-title":"Psychometric properties of nine scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale","volume":"11","author":"Weathers","year":"1999","journal-title":"Psychological Assessment"},{"key":"10.1002\/14651858.CD002795.pub3-BIB0317|cit317","first-page":"399","volume-title":"Assessing psychological trauma and PTSD: a handbook for practitioners","author":"Weiss","year":"1997"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0318|cit318","first-page":"340","article-title":"Buspirone in the treatment of post-traumatic stress disorder and dream anxiety disorder","volume":"11","author":"Wells","year":"1991","journal-title":"Military Medicine"},{"issue":"11","key":"10.1002\/14651858.CD002795.pub3-BIB0319|cit319","first-page":"1061","article-title":"Post-traumatic stress disorder","volume":"34","author":"White","year":"1983","journal-title":"Hospital and Community Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD002795.pub3-BIB0320|cit320","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1176\/ajp.152.12.1705","article-title":"Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis","volume":"152","author":"Yehuda","year":"1995","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD002795.pub3-BIB0321|cit321","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002795","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Stein","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD002795.pub3-BIB0322|cit322","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002795.pub2","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","author":"Stein","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002795.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T08:25:58Z","timestamp":1687854358000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002795.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":322,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002795.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}